Bruker (BRKR) Liabilities and Shareholders Equity (2010 - 2026)

Bruker's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $6.1 billion for Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 3.33% year-over-year to $6.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.1 billion (up 5.86% YoY) and the FY2025 annual result came in at $6.2 billion, up 7.49% from the prior year.
• Liabilities and Shareholders Equity was $6.1 billion for Q1 2026 at Bruker, down from $6.2 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $6.4 billion in Q3 2025 and bottomed at $3.3 billion in Q3 2022.
• A 5-year average of $4.9 billion and a median of $4.5 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity decreased 1.05% — and 2024, when it surged 60.04%.
• Bruker's Liabilities and Shareholders Equity stood at $3.6 billion in 2022, then climbed by 17.67% to $4.2 billion in 2023, then soared by 36.63% to $5.8 billion in 2024, then grew by 7.49% to $6.2 billion in 2025, then retreated by 1.77% to $6.1 billion in 2026.
• Business Quant data shows BRKR's Liabilities and Shareholders Equity at $6.1 billion in Q1 2026, $6.2 billion in Q4 2025, and $6.4 billion in Q3 2025.